Cargando…

Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria

ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibio...

Descripción completa

Detalles Bibliográficos
Autores principales: Moghadam, Majid Taati, Mojtahedi, Ali, Moghaddam, Mehrdad Moosazadeh, Fasihi-Ramandi, Mahdi, Mirnejad, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125544/
https://www.ncbi.nlm.nih.gov/pubmed/35604438
http://dx.doi.org/10.1007/s00253-022-11940-z
_version_ 1784711959143251968
author Moghadam, Majid Taati
Mojtahedi, Ali
Moghaddam, Mehrdad Moosazadeh
Fasihi-Ramandi, Mahdi
Mirnejad, Reza
author_facet Moghadam, Majid Taati
Mojtahedi, Ali
Moghaddam, Mehrdad Moosazadeh
Fasihi-Ramandi, Mahdi
Mirnejad, Reza
author_sort Moghadam, Majid Taati
collection PubMed
description ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibiotics have continued to the point that humanity today is almost helpless in the fight against infection. Researchers have predicted that by the middle of the new century, there will be a dark period after the production of antibiotics that doctors will encounter antibiotic-resistant infections for which there is no cure. Accordingly, researchers are looking for new materials with antimicrobial properties that will strengthen their ammunition to fight antibiotic-resistant infections. One of the most important alternatives to antibiotics introduced in the last three decades is antimicrobial peptides (AMPs), which affect a wide range of microbes. Due to their different antimicrobial properties from antibiotics, AMPs can fight and kill MDR, XDR, and colistin-resistant bacteria through a variety of mechanisms. Therefore, in this study, we intend to use the latest studies to give a complete description of AMPs, the importance of colistin-resistant bacteria, and their resistance mechanisms, and represent impact of AMPs on colistin-resistant bacteria. KEY POINTS: • AMPs as limited options to kill colistin-resistant bacteria. • Challenge of antibiotics resistance, colistin resistance, and mechanisms. • What is AMPs in the war with colistin-resistant bacteria?
format Online
Article
Text
id pubmed-9125544
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-91255442022-05-23 Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria Moghadam, Majid Taati Mojtahedi, Ali Moghaddam, Mehrdad Moosazadeh Fasihi-Ramandi, Mahdi Mirnejad, Reza Appl Microbiol Biotechnol Mini-Review ABSTRACT: It has been about a century since the discovery of the first antibiotic, and during this period, several antibiotics were produced and marketed. The production of high-potency antibiotics against infections led to victories, but these victories were temporary. Overuse and misuse of antibiotics have continued to the point that humanity today is almost helpless in the fight against infection. Researchers have predicted that by the middle of the new century, there will be a dark period after the production of antibiotics that doctors will encounter antibiotic-resistant infections for which there is no cure. Accordingly, researchers are looking for new materials with antimicrobial properties that will strengthen their ammunition to fight antibiotic-resistant infections. One of the most important alternatives to antibiotics introduced in the last three decades is antimicrobial peptides (AMPs), which affect a wide range of microbes. Due to their different antimicrobial properties from antibiotics, AMPs can fight and kill MDR, XDR, and colistin-resistant bacteria through a variety of mechanisms. Therefore, in this study, we intend to use the latest studies to give a complete description of AMPs, the importance of colistin-resistant bacteria, and their resistance mechanisms, and represent impact of AMPs on colistin-resistant bacteria. KEY POINTS: • AMPs as limited options to kill colistin-resistant bacteria. • Challenge of antibiotics resistance, colistin resistance, and mechanisms. • What is AMPs in the war with colistin-resistant bacteria? Springer Berlin Heidelberg 2022-05-23 2022 /pmc/articles/PMC9125544/ /pubmed/35604438 http://dx.doi.org/10.1007/s00253-022-11940-z Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Mini-Review
Moghadam, Majid Taati
Mojtahedi, Ali
Moghaddam, Mehrdad Moosazadeh
Fasihi-Ramandi, Mahdi
Mirnejad, Reza
Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title_full Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title_fullStr Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title_full_unstemmed Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title_short Rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
title_sort rescuing humanity by antimicrobial peptides against colistin-resistant bacteria
topic Mini-Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125544/
https://www.ncbi.nlm.nih.gov/pubmed/35604438
http://dx.doi.org/10.1007/s00253-022-11940-z
work_keys_str_mv AT moghadammajidtaati rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria
AT mojtahediali rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria
AT moghaddammehrdadmoosazadeh rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria
AT fasihiramandimahdi rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria
AT mirnejadreza rescuinghumanitybyantimicrobialpeptidesagainstcolistinresistantbacteria